medigraphic.com
ISSN 2307-2113 (Electronic)
Revista Cubana de Información en Ciencias de la Salud (ACIMED)

2019, Number 4

<< Back Next >>

Revista Cubana de Información en Ciencias de la Salud (ACIMED) 2019; 30 (4)

Telehealth in Latin America: A review of the studies registered in clinicaltrials.gov

Quispe-Juli CU, Moquillaza-Alcántara VH, Arapa-Apaza KL

Language: Spanish
References: 18
Page: 1-12
PDF size: 347.05 Kb.


ABSTRACT

The characteristics and trends of telehealth research in Latin America, especially clinical trials, have been little explored. The objective was to characterize the studies registered in clinicaltrials.gov about telehealth in Latin America. We performed an observational and descriptive study and evaluated the telehealth research in Latin America registered until 2018 in clinicaltrials.gov. The type of study, disease, country, initiative and type of institution were evaluated. We found 37 studies registered. The studies on telehealth were mainly clinical trials of parallel assignment type (81.1%). The most discussed diseases were: arterial hypertension (23.9%), diabetes (11.3%) and cardiovascular diseases (9.9%). The 64.9% of the works were local initiatives, being Brazil (29.3%) and Argentina (14.6%) the countries with the highest number of investigations. In conclusion, there is a low number of Latin American studies registered in clinicaltrials.gov, the studies focused mainly on chronic diseases and were developed by local initiative. We need more clinical trials on telehealth in the Latin American context to help to consolidate its development.


REFERENCES

  1. Tuckson RV, Edmunds M, Hodgkins ML. Telehealth. N Engl J Med. 2017;377(16):1585-92.DOI: 10.1056/NEJMsr1503323

  2. Celes RS, Rossi TRA, Barros SG, Santos CML, Cardoso C. A telessaúde como estratégia deresposta do Estado: revisão sistemática. Rev Panam Salud Pública. 2018;42: e84. DOI: 10.26633/RPSP.2018.84

  3. LeRouge CM, Gupta M, Corpart G, Arrieta A. Health system approaches are needed toexpand telemedicine use across nine Latin American Nations. Health Affairs. 2019;38(2):212-21.DOI: 10.1377/hlthaff.2018.05274

  4. Law LM, Wason JMS. Design of telehealth trials - Introducing adaptive approaches. Int J MedInform. 2014; 83(12): 870-80. DOI: 10.1016/j.ijmedinf.2014.09.002

  5. Flumignan CDQ, Rocha APD, Pinto ACPN, Milby KMM, Batista MR, Atallah ÁN, SaconatoH. What do Cochrane systematic reviews say about telemedicine for healthcare? Sao Paulo Med J. 2019;137(2):184-92. DOI: 10.1590/1516-3180.0177240419

  6. Wang MT, Bolland MJ, Grey A. Reporting of Limitations of Observational Research. JAMAIntern Med. 2015;175(9):1571-2. DOI: 10.1001/jamainternmed.2015.2147

  7. Groneberg DA, Rahimian S, Bundschuh M, Schwarzer M, Gerber A, Kloft B. Telemedicine- a scientometric and density equalizing analysis. J Occup Med Toxicol. 2015; 10:38. DOI: 10.1186/s12995-015-0076-3.

  8. Tse T, Fain KM, Zarin DA. How to avoid common problems when using ClinicalTrials.govin research: 10 issues to consider. BMJ. 2018;361:1452.

  9. US National Library of Medicine ClinicalTrials.gov [Internet]. Washington D.C.: USNational Library of Medicine; 2019 [acceso: 07/11/2019]. Disponible en: http://www.clinicaltrials.gov

  10. Ohannessian R, Yaghobian S, Chaleuil M, Salles N. Telemedicine in France: A review ofregistered clinical trials from 2000 to 2015. Eur Res Telemed [Internet]. 2016 [acceso: 07/11/2019];5(2):29-36. DOI: 10.1016/j.eurtel.2016.04.001

  11. Lwoga ET, Sangeda RZ. ICTs and development in developing countries: A systematicreview of reviews. E J Info Sys Dev Countries [Internet]. 2019 [acceso: 07/11/2019];85(1):e12060. DOI: 10.1002/isd2.12060

  12. Novillo-Ortiz D, Dumit EM, D'Agostino M, Becerra-Posada F, Kelley ET, Torrent-SellensJ, et al. Digital health in the Americas: advances and challenges in connected health. BMJ Innov. 2018 [acceso: 07/11/2019];4(3):123-7. DOI: 10.1136/bmjinnov-2017-000258

  13. Finet P, Le Bouquin Jeannè R, Dameron O, Gibaud B. Review of current telemedicineapplications for chronic diseases. Toward a more integrated system? IRBM [Internet]. 2015 [citado 07 Nov 2019]; 36(3):133-57. DOI: 10.1016/j.irbm.2015.01.009

  14. McPhail SM. Multimorbidity in chronic disease: impact on health care resources and costs.Risk Manag Healthc Policy [Internet]. 2016 [acceso: 07/11/2019];9:143-56. DOI: 10.2147/RMHP.S97248

  15. Wechsler LR. American Heart Association Stroke Council; Council on Epidemiology andPrevention; Council on Quality of Care and Outcomes Research. Telemedicine quality and outcomes in stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke [Internet]. 2017 [acceso: 07/11/2019];48(1):e3-e25. DOI: 10.1161/STR.0000000000000114

  16. Vranas KC, Slatore CG, Kerlin MP. Telemedicine Coverage of Intensive Care Units: A Narrative Review. Ann Am Thorac Soc [Internet]. 2018 [acceso: 07/11/2019];15(11):1256-64. DOI: 10.1513/AnnalsATS.201804-225CME

  17. Santos AF, D’Agostino M, Bouskela MS, Fernandéz A, Messina LA, Alves HJ. Uma visão panorámica das ações de telessaúde na América Latina. Rev Panam Salud Publica [Internet]. 2014 [acceso: 07/11/2019];35(5/6):465-70

  18. Dinesen B, Nonnecke B, Lindeman D, Toft E, Kidholm K, Jethwani K et al. Personalized Telehealth in the Future: A Global Research Agenda. J Med Internet Res [Internet]. 2016 [acceso: 07/11/2019];18(3):e53. DOI: 10.2196/jmir.5257




2020     |     www.medigraphic.com